Related Experiment Videos
Carbamazepine in mixed frontal lobe and psychiatric disorders
The Journal of Clinical Psychiatry
|September 1, 1985
Abstract:
Carbamazepine was given to five patients with mixed frontal lobe disease and a variety of primary psychiatric disorders. All five patients benefited significantly. A decrease in affective lability was the most consistent result. Carbamazepine may be an alternative to chronic high-dose neuroleptic therapy in these patients.